HIV Research & Community Colloquia Series: Using Data to Set HIV Prevention Priorities in Los Angeles
Date(s) - Apr 11, 2013
9:00 AM - 11:00 AM
The Los Angeles HIV Research & Community Colloquia Series Hosted by the Los Angeles County Commission on HIV, Prevention Planning Committee, and UCLA Center for HIV Identification, Prevention, Treatment Services
Findings from HIV Prevention Trials Network 061 Study: Using Data to Set HIV Prevention Priorities in Los Angeles
Steven Shoptaw, PhD
Executive Director, UCLA Center for Behavioral and Addiction Medicine
Professor/Vice Chair for Academic Affairs, UCLA Department of Family Medicine
Date/Time (PLEASE NOTE NEW TIME):
Thursday, April 11, 2013
9:00am to 11:00 am
It is a one hour presentation, followed by a community panel discussion.
(NO REGISTRATION NEEDED, OPEN MEETING)
St. Anne’s Maternity Home – Foundation Conference Room
155 N. Occidental Blvd.
Los Angeles, CA 90026
Download the presentation here: Shoptaw 4.11.13 (241)
The HIV Prevention Trials Network 061 study (as known as The BROTHERS study) remains the largest prospective, multi-site study in the United States for Black men who have sex with men (MSM). This is remarkable given the disproportionate burden of both HIV incidence and prevalence among Black MSM. The study was conducted in 6 cities including Atlanta, Boston, New York, Los Angeles, San Francisco, and Washington, DC. Findings address the following over the 1-year cohort study: HIV and STD incidence, rate of newly diagnosed HIV, history of HIV testing, correlates of HIV incidence, rates of incarceration, and rates of reported substance use. Results focusing exclusively on the HIV epidemic in Los Angeles show an unacceptably high HIV incidence and represent a current health crisis among Black MSM in the city. Results highlight factors that challenge a comprehensive HIV prevention response to the situation with Black MSM, both HIV-negative and HIV-positive. These factors include: (1) Black MSM engage sexual risk behaviors at similar rates to MSM from other racial ethnic groups, meaning that more behavioral HIV prevention programs may have limited impact; (2) Black MSM living with HIV are likely to have poor health outcomes at each level of the treatment cascade; (3) Black MSM encounter stifling structural problems (employment, stigma, discrimination, legal) that compromise capacity to provide for survival needs and for sexual, primary and HIV-health care; and (4) young Black MSM experience high rates of HIV seroconversion.
Steven Shoptaw, PhD is Executive Director of the UCLA Center for Behavioral and Addiction Medicine, which works to advance the prevention and treatment of chronic illnesses, especially in communities with health disparities. He is a licensed psychologist and Professor in both Departments of Family Medicine and Psychiatry and Biobehavioral Sciences at UCLA. Over the past 20 years, Dr. Shoptaw has conducted a series of clinical studies in community clinic settings, primarily on topics that involve developing and testing medical and behavioral interventions to treat substance abuse and prevent the spread of HIV. He works with a broad spectrum of partners from university, government and community settings. In addition, he maintains a regular caseload of patients and provides training and mentorship to students and postdoctoral fellows. Dr. Shoptaw’s CV boasts more than 150 peer-reviewed journal articles and over a dozen book chapters. He lectures regularly on the UCLA campus, as well as in community-based organizations. He sits on multiple planning committees for the L.A. Department of Public Health and trains service providers at County-funded clinics. Internationally, Dr. Shoptaw has consulted with the United Nations to develop technical guidelines for HIV prevention, treatment and care among stimulant users.